Skip to main content
Erschienen in: Cancer Causes & Control 1/2015

01.01.2015 | Brief report

International testicular cancer incidence trends: generational transitions in 38 countries 1900–1990

verfasst von: Ariana Znaor, Joannie Lortet-Tieulent, Mathieu Laversanne, Ahmedin Jemal, Freddie Bray

Erschienen in: Cancer Causes & Control | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Rapid increases in testicular cancer incidence have marked the second half of the last century. While these secular rises, observed mainly in countries attaining the highest levels of human development, appear to have attenuated in the last decade, rates continue to increase in countries transiting toward high developmental levels. The purpose of our study was to provide a comprehensive analysis and presentation of the cohort-specific trends in testicular cancer incidence rates in 38 countries worldwide.

Methods

We used an augmented version of the Cancer Incidence in Five Continents series to analyze testicular cancer incidence in men aged 15–54 in 38 countries, via age–period–cohort analysis.

Results

In many European countries, the USA, Canada, Australia, and New Zealand, there is a continuation of the increasing risk among successive generations, yet rates are attenuating in male cohorts born since the 1970s in several Northern European countries, in contrast to the steeply increasing trends in recent cohorts in Southern Europe. Incidence rates have also been increasing in the populations traditionally at rather low risk, such as in the Philippines, Singapore, China, and Costa Rica.

Conclusions

The attenuation of testicular cancer risk in younger generations (in the most developed countries) alongside concomitant increases (in countries undergoing developmental change) is indicative of a global transition in the risk of testicular cancer. While identifying the underlying causes remains a major challenge, increasing awareness and adapting national healthcare systems to accommodate a growing burden of testicular cancer may prevent future avoidable deaths in young men.
Literatur
1.
Zurück zum Zitat Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H (2006) Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 118(12):3099–3111PubMedCrossRef Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H (2006) Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 118(12):3099–3111PubMedCrossRef
2.
Zurück zum Zitat Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA (2010) International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev 19(5):1151–1159PubMedCentralPubMedCrossRef Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA (2010) International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev 19(5):1151–1159PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Ferlay J, Soerjomataram I, Ervik M, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon, France. http://globocan.iarc.fr Ferlay J, Soerjomataram I, Ervik M, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon, France. http://​globocan.​iarc.​fr
4.
Zurück zum Zitat Bergstrom R, Adami HO, Mohner M et al (1996) Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 88(11):727–733PubMedCrossRef Bergstrom R, Adami HO, Mohner M et al (1996) Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 88(11):727–733PubMedCrossRef
5.
Zurück zum Zitat Bray F, Richiardi L, Ekbom A et al (2006) Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev 15(4):652–658PubMedCrossRef Bray F, Richiardi L, Ekbom A et al (2006) Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev 15(4):652–658PubMedCrossRef
6.
Zurück zum Zitat Richiardi L, Bellocco R, Adami HO et al (2004) Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13(12):2157–2166PubMed Richiardi L, Bellocco R, Adami HO et al (2004) Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13(12):2157–2166PubMed
7.
Zurück zum Zitat Verhoeven R, Houterman S, Kiemeney B, Koldewijn E, Coebergh JW (2008) Testicular cancer: marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970. Int J Cancer 122(3):639–642PubMedCrossRef Verhoeven R, Houterman S, Kiemeney B, Koldewijn E, Coebergh JW (2008) Testicular cancer: marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970. Int J Cancer 122(3):639–642PubMedCrossRef
8.
Zurück zum Zitat Kanetsky PA, Mitra N, Vardhanabhuti S et al (2009) Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet 41(7):811–815PubMedCentralPubMedCrossRef Kanetsky PA, Mitra N, Vardhanabhuti S et al (2009) Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet 41(7):811–815PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Chung CC, Kanetsky PA, Wang Z et al (2013) Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet 45(6):680–685PubMedCrossRef Chung CC, Kanetsky PA, Wang Z et al (2013) Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet 45(6):680–685PubMedCrossRef
10.
Zurück zum Zitat Ruark E, Seal S, McDonald H et al (2013) Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. Nat Genet 45(6):686–689PubMedCrossRef Ruark E, Seal S, McDonald H et al (2013) Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. Nat Genet 45(6):686–689PubMedCrossRef
11.
Zurück zum Zitat McGlynn KA (2001) Environmental and host factors in testicular germ cell tumors. Cancer Invest 19(8):842–853PubMedCrossRef McGlynn KA (2001) Environmental and host factors in testicular germ cell tumors. Cancer Invest 19(8):842–853PubMedCrossRef
12.
Zurück zum Zitat Garner MJ, Turner MC, Ghadirian P, Krewski D (2005) Epidemiology of testicular cancer: an overview. Int J Cancer 116(3):331–339PubMedCrossRef Garner MJ, Turner MC, Ghadirian P, Krewski D (2005) Epidemiology of testicular cancer: an overview. Int J Cancer 116(3):331–339PubMedCrossRef
13.
Zurück zum Zitat Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA (2009) A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer–experiences of the mother. Int J Epidemiol 38(6):1532–1542PubMedCentralPubMedCrossRef Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA (2009) A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer–experiences of the mother. Int J Epidemiol 38(6):1532–1542PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA (2010) A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer–experiences of the son. Int J Epidemiol 39(6):1605–1618PubMedCentralPubMedCrossRef Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA (2010) A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer–experiences of the son. Int J Epidemiol 39(6):1605–1618PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Bosetti C, Bertuccio P, Chatenoud L, Negri E, La Vecchia C, Levi F (2011) Trends in mortality from urologic cancers in Europe, 1970–2008. Eur Urol 60(1):1–15PubMedCrossRef Bosetti C, Bertuccio P, Chatenoud L, Negri E, La Vecchia C, Levi F (2011) Trends in mortality from urologic cancers in Europe, 1970–2008. Eur Urol 60(1):1–15PubMedCrossRef
16.
Zurück zum Zitat Levi F, La Vecchia C, Boyle P, Lucchini F, Negri E (2001) Western and eastern European trends in testicular cancer mortality. Lancet 357(9271):1853–1854PubMedCrossRef Levi F, La Vecchia C, Boyle P, Lucchini F, Negri E (2001) Western and eastern European trends in testicular cancer mortality. Lancet 357(9271):1853–1854PubMedCrossRef
18.
Zurück zum Zitat Znaor A, Bray F (2012) Thirty year trends in testicular cancer mortality in Europe: gaps persist between the East and West. Acta Oncol 51(7):956–958PubMedCrossRef Znaor A, Bray F (2012) Thirty year trends in testicular cancer mortality in Europe: gaps persist between the East and West. Acta Oncol 51(7):956–958PubMedCrossRef
19.
Zurück zum Zitat Bertuccio P, Malvezzi M, Chatenoud L et al (2007) Testicular cancer mortality in the Americas, 1980–2003. Cancer 109(4):776–779PubMedCrossRef Bertuccio P, Malvezzi M, Chatenoud L et al (2007) Testicular cancer mortality in the Americas, 1980–2003. Cancer 109(4):776–779PubMedCrossRef
20.
Zurück zum Zitat McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97(1):63–70PubMedCrossRef McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97(1):63–70PubMedCrossRef
21.
Zurück zum Zitat Ferlay J, Parkin DM, Curado MP, Bray F, Edwards B, Shin HR, Forman D (2010) Cancer incidence in five continents, volumes I to IX: IARC CancerBase No. 9. International Agency for Research on Cancer, Lyon, France. http://ci5.iarc.fr Ferlay J, Parkin DM, Curado MP, Bray F, Edwards B, Shin HR, Forman D (2010) Cancer incidence in five continents, volumes I to IX: IARC CancerBase No. 9. International Agency for Research on Cancer, Lyon, France. http://​ci5.​iarc.​fr
22.
Zurück zum Zitat Doll R, Payne P, Waterhouse J (1966) Cancer incidence in five continents, vol I. Union Internationale Contre le Cancer, Geneva, Switzerland Doll R, Payne P, Waterhouse J (1966) Cancer incidence in five continents, vol I. Union Internationale Contre le Cancer, Geneva, Switzerland
23.
Zurück zum Zitat Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med 6(4):449–467PubMedCrossRef Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med 6(4):449–467PubMedCrossRef
24.
Zurück zum Zitat Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. II: age–period–cohort models. Stat Med 6(4):469–481PubMedCrossRef Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. II: age–period–cohort models. Stat Med 6(4):469–481PubMedCrossRef
25.
Zurück zum Zitat Rutherford M, Lambert P, Thompson J (2010) Age-Period-cohort modelling. Stata J 10(4):606–627 Rutherford M, Lambert P, Thompson J (2010) Age-Period-cohort modelling. Stata J 10(4):606–627
26.
Zurück zum Zitat StataCorp LP (2011) Stata statistical software. College Station, TX StataCorp LP (2011) Stata statistical software. College Station, TX
27.
Zurück zum Zitat Skakkebaek NE, Rajpert-De ME, Jorgensen N et al (2007) Testicular cancer trends as ‘whistle blowers’ of testicular developmental problems in populations. Int J Androl 30(4):198–204PubMedCrossRef Skakkebaek NE, Rajpert-De ME, Jorgensen N et al (2007) Testicular cancer trends as ‘whistle blowers’ of testicular developmental problems in populations. Int J Androl 30(4):198–204PubMedCrossRef
28.
Zurück zum Zitat Skakkebaek NE, Berthelsen JG, Giwercman A, Muller J (1987) Carcinoma-in situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10(1):19–28PubMedCrossRef Skakkebaek NE, Berthelsen JG, Giwercman A, Muller J (1987) Carcinoma-in situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10(1):19–28PubMedCrossRef
29.
Zurück zum Zitat Moller H (1989) Decreased testicular cancer risk in men born in wartime. J Natl Cancer Inst 81(21):1668–1669PubMedCrossRef Moller H (1989) Decreased testicular cancer risk in men born in wartime. J Natl Cancer Inst 81(21):1668–1669PubMedCrossRef
30.
Zurück zum Zitat Moller H (1993) Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 23(1):8–13PubMed Moller H (1993) Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 23(1):8–13PubMed
31.
Zurück zum Zitat Le Cornet C, Lortet-Tieulent J, Forman D et al (2013) Testicular cancer incidence to rise by 25 % by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data. Eur J Cancer 50(4):831–839PubMedCrossRef Le Cornet C, Lortet-Tieulent J, Forman D et al (2013) Testicular cancer incidence to rise by 25 % by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data. Eur J Cancer 50(4):831–839PubMedCrossRef
Metadaten
Titel
International testicular cancer incidence trends: generational transitions in 38 countries 1900–1990
verfasst von
Ariana Znaor
Joannie Lortet-Tieulent
Mathieu Laversanne
Ahmedin Jemal
Freddie Bray
Publikationsdatum
01.01.2015
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 1/2015
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0486-z

Weitere Artikel der Ausgabe 1/2015

Cancer Causes & Control 1/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.